{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:21:27Z","timestamp":1788114087009,"version":"build-2803163510"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/dsu.12319","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T02:37:53Z","timestamp":1381545473000},"page":"1733-1744","source":"Crossref","is-referenced-by-count":17,"title":["Spotlighting the Role of Photodynamic Therapy in Cutaneous Malignancy: An Update and Expansion"],"prefix":"10.1097","volume":"39","author":[{"given":"Kate","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Cherpelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210206","first-page":"3591","article-title":"An outline of the history of PDT.","volume":"23","author":"Moan","year":"2003","journal-title":"Anticancer Res"},{"key":"R2-1-20210206","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.sder.2011.08.001","article-title":"Photodynamic therapy: current evidence and applications in dermatology.","volume":"30","author":"Lee","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"R3-1-20210206","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1040-8428(84)80016-5","article-title":"Photodynamic therapy (PDT) of malignant tumors.","volume":"2","author":"Dougherty","year":"1984","journal-title":"Crit Rev Oncol Hematol"},{"key":"R4-1-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol"},{"key":"R5-1-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus.","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R6-1-20210206","first-page":"109","article-title":"Photodynamic therapy in melanoma- An Update.","volume":"62","author":"Baldea","year":"2012","journal-title":"J Physiol Pharmacol"},{"key":"R7-1-20210206","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1468-3083.2011.04432.x","article-title":"Photodynamic therapy for skin field cancerization: an international consensus. International society for photodynamic therapy in dermatology.","volume":"26","author":"Braathen","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-1-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00403-011-1122-3","article-title":"Photosensitizers and light sources for photodynamic therapy of the Bowens disease.","volume":"303","author":"Calin","year":"2011","journal-title":"Arch Dermatol"},{"key":"R9-1-20210206","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2133.2000.03773.x","article-title":"Comparison of red and green light in the treatment of Bowens disease by photodynamic therapy.","volume":"143","author":"Morton","year":"2000","journal-title":"Br J Dermatol"},{"key":"R10-1-20210206","first-page":"218","article-title":"Preferential relative porphyrin enrichement in solar keratoses upon topical application of delta-aminolevulinic acid methylester.","volume":"68","author":"Fritsch","year":"1998","journal-title":"Photochem Photobiology"},{"key":"R11-1-20210206","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lsm.20984","article-title":"Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phage 1 clincal trial.","volume":"42","author":"Baron","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R12-1-20210206","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09546630902882048","article-title":"Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3 gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.","volume":"20","author":"Van Der Geer","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"R13-1-20210206","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jaad.2011.11.933","article-title":"A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5 verses sequential application of both therapies in immunocompetant patients with actinic keratosis: clinical and histologic outcomes.","volume":"66","author":"Serra-Guillen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R14-1-20210206","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1365-2133.2012.11103.x","article-title":"A randomized, half-side comparative study of aminolevulinate photodynamic therapy versus CO2 laser ablation in immunocompetent patients with multiple actinic keratosis.","volume":"167","author":"Scola","year":"2012","journal-title":"Br J Dermatol"},{"key":"RU15-1-20210206","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2006.07470.x","article-title":"Intraindividual, right-left comparison of topical methyl-aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.","volume":"155","author":"Morton","year":"2006","journal-title":"Br J Dermatol"},{"key":"RU16-1-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1610-0387.2007.06555.x","article-title":"Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system.","volume":"6","author":"Balibas","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"RU17-1-20210206","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2008.08488.x","article-title":"Multicentre intraindividual randomized trial of topical methyl aminoaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.","volume":"158","author":"Kaufman","year":"2008","journal-title":"Br J Dermatol"},{"key":"RU18-1-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2008.05.031","article-title":"Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study.","volume":"59","author":"Pariser","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"RU19-1-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.2007.07946.x","article-title":"Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.","volume":"157","author":"Moloney","year":"2007","journal-title":"Br J Dermatol"},{"key":"RU20-1-20210206","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1524-4725.2009.01096.x","article-title":"Topical methyl-aminlevulinate photodynamic therapy using red light-emitting diode for mutiple actinic keratoses: a randomized study.","volume":"35","author":"Szeimies","year":"2009","journal-title":"Dermatol Surg"},{"key":"RU21-1-20210206","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2008.03029.x","article-title":"Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.","volume":"23","author":"Braathen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU22-1-20210206","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"RU23-1-20210206","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1365-2133.2009.09040.x","article-title":"Optimization of photodynamic therapy with a novel self-adhesive patch: results of two randomized controlled phase III studies.","volume":"160","author":"Hauschild","year":"2009","journal-title":"Br J Dermatol"},{"key":"RU24-1-20210206","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1468-3083.2009.03259.x","article-title":"Intraindividual, right-left comparison of topical 5-aminolevulinic acid and photodynamic therapy vs. 5 imiquimod cream for actinic keratoses on the upper extremities.","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU25-1-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","article-title":"Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicenter, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolevulinate cream and placebo.","volume":"166","author":"Dirschka","year":"2012","journal-title":"Br J Dermatol"},{"key":"RU26-1-20210206","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1524-4725.2012.02340.x","article-title":"Results of an investigator-initiated, single-blind split-face comparison of photodynamic therapy and 5 imiquimod cream for the treatment of actinic keratoses.","volume":"38","author":"Hadley","year":"2012","journal-title":"Dermatol Surg"},{"key":"R27-1-20210206","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1346-8138.2010.00850.x","article-title":"Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowens Disease.","volume":"37","author":"Hasegawa","year":"2010","journal-title":"J Dermatol"},{"key":"R28-1-20210206","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0781.2012.00658.x","article-title":"Comparison of the efficacy using an excimer-dye laser (630 nm) and a metal halide lamp (600-740 nm) for the treatment of bowens disease.","volume":"28","author":"Mizutani","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R29-1-20210206","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0161-5890(03)00083-X","article-title":"Photodynamic therapy for nonmelanoma skin cancers: current review and update.","volume":"39","author":"Zetouni","year":"2003","journal-title":"Mol Immunol"},{"key":"RU30-1-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl amminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ.","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"key":"RU31-1-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2008.08593.x","article-title":"Methylaminolaevulinate-based photodynamic therapy of Bowens disease and squamous cell carcinoma.","volume":"159","author":"Calzavara-Pinton","year":"2008","journal-title":"Br J Dermatol"},{"key":"RU32-1-20210206","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1468-3083.2011.04175.x","article-title":"Effectiveness of photodynamic therapy in Bowens disease: an observational and descriptive study in 51 lesions.","volume":"26","author":"Truchuelo","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU33-1-20210206","first-page":"319","article-title":"Photodynamic therapy for large or multiple patches of Bowens disease and Basal cell carcinoma.","volume":"137","author":"Morton","year":"2001","journal-title":"Arch Dermatol"},{"key":"R34-1-20210206","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/pho.2009.2610","article-title":"Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.","volume":"28","author":"Li","year":"2010","journal-title":"Photomed Laser Surg"},{"key":"R35-1-20210206","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/0378-6323.93634","article-title":"Efficacy of topical photodynamic therapy for keratoacanthomas: a case-series of four patients.","volume":"78","author":"Farias","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"RU36-1-20210206","first-page":"412","article-title":"MAL-PDT versus cryotherapy in primary sBCC: results of 36 months follow-up.","volume":"18","author":"Basset-Seguin","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU37-1-20210206","first-page":"237","article-title":"MAL-PDT vs cryotherapy in primary sBCC: results of 48-month follow up.","volume":"19","author":"Basset-Seguin","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU38-1-20210206","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"key":"RU39-1-20210206","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1468-3083.2008.02946.x","article-title":"Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curretage in basal cell carcinoma: a 6 year clinical and histological follow up.","volume":"23","author":"Christensen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"RU40-1-20210206","first-page":"1342","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10 year follow up study.","volume":"166","author":"Christensen","year":"2012","journal-title":"Arch Dermatol"},{"key":"R41-1-20210206","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1468-3083.2012.04619.x","article-title":"Photodynamic therapy using topical 5-aminolevulinic acid vs. surgery for basal cell carcinoma.","volume":"27","author":"Cosgarea","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-1-20210206","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br J Dermatol"},{"key":"R43-1-20210206","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"R44-1-20210206","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2010.03877.x","article-title":"Photodynamic therapy for basal cell carcinoma: clinical and pathological determinates of response.","volume":"25","author":"Fantini","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R45-1-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.140.1.17","article-title":"Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.","volume":"140","author":"Rhodes","year":"2004","journal-title":"Arch Dermatol"},{"key":"R46-1-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.2004.06047.x","article-title":"Mohs micrographic surgery for treatment of basal cell carcinoma of the faceresults of a retrospective study and review of the literature.","volume":"151","author":"Smeets","year":"2004","journal-title":"Br J Dermatol"},{"key":"R47-1-20210206","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2010.03.045","article-title":"Photodynamic therapy of tumor margins using methyl aminolevulinate before Mohs micrographic surgery.","volume":"64","author":"Tierney","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"RU48-1-20210206","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2001.04141.x","article-title":"Photodynamic therapy vs. Cryosurgery of basal cell carcinomas: results of a phase III clinical trial.","volume":"144","author":"Wang","year":"2001","journal-title":"Br J Dermatol"},{"key":"RU49-1-20210206","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.","volume":"5","author":"Kuijpers","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"RU50-1-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1615\/JEnvironPatholToxicolOncol.v25.i1-2.260","article-title":"Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery.","volume":"25","author":"Thompson","year":"2006","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"R51-1-20210206","first-page":"593","article-title":"Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.","volume":"11","author":"Goldberg","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"R52-1-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2009.09492.x","article-title":"Skin Cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.","volume":"162","author":"Apalla","year":"2010","journal-title":"Br J Dermatol"},{"key":"R53-1-20210206","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archdermatol.2011.3080","article-title":"Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma.","volume":"148","author":"Alloo","year":"2012","journal-title":"Arch Dermatol"},{"key":"RU54-1-20210206","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2004.06054.x","article-title":"A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.","volume":"151","author":"Dragieva","year":"2004","journal-title":"Br J Dermatol"},{"key":"RU55-1-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil and topical photodynamic therapy.","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"key":"RU56-1-20210206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/TP.0b013e318180731e","article-title":"Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study.","volume":"86","author":"Wennberg","year":"2008","journal-title":"Transplantation"},{"key":"RU57-1-20210206","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0378-6323.98075","article-title":"Topical photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses and reduction of photodamage in organ transplant recipients: a case series of 16 patients.","volume":"78","author":"Hasson","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"RU58-1-20210206","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2230.2011.04248.x","article-title":"Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.","volume":"37","author":"Guleng","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"RU59-1-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.TP.0000107284.04969.5C","article-title":"Topical photodynamic therapy in the treatment of actinic keratoses and Bowens disease in transplant recipients.","volume":"77","author":"Dragieva","year":"2004","journal-title":"Transplantation"},{"key":"RU60-1-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.jid.5700098","article-title":"Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial.","volume":"126","author":"De Graaf","year":"2006","journal-title":"J Invest Dermatol"},{"key":"RU61-1-20210206","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1524-4725.2009.01384.x","article-title":"Reduction in the incidence of squamous cell carcinoa in solid organ transplant recipients treated with cyclic photodynamic therapy.","volume":"36","author":"Willey","year":"2010","journal-title":"Dermatol Surg"},{"key":"R62-1-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000246057","article-title":"Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.","volume":"194","author":"Wolf","year":"1997","journal-title":"Dermatology"},{"key":"R63-1-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1615\/JEnvironPatholToxicolOncol.v26.i3.10","article-title":"A new method for photodynamic therapy of melanotic melanomaeffects of depigmentation with violet light photodynamic therapy.","volume":"26","author":"Ma","year":"2007","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"R64-1-20210206","first-page":"179","article-title":"The potential role of photodynamic therapy in the treatment of malignant melanomaan in vitro study.","volume":"21","author":"Choromanska","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"R65-1-20210206","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/hsz-2012-0228","article-title":"Melanoma resistance to photodynamic therapy: new insights.","volume":"394","author":"Huang","year":"2013","journal-title":"Biol Chem"},{"key":"R66-1-20210206","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0781.2006.00246.x","article-title":"Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.","volume":"22","author":"Zane","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R67-1-20210206","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pdpdt.2008.03.001","article-title":"Photodynamic therapy: off-label and alternative use in dermatological practice.","volume":"5","author":"Buggiani","year":"2008","journal-title":"Photodiagn Photodyn Ther"},{"key":"R68-1-20210206","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0190-9622(95)91413-7","article-title":"Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.","volume":"33","author":"Ammann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"RU69-1-20210206","first-page":"75","article-title":"Unilesional mycosis fungoides treated with photodynamic therapy. A case report.","volume":"17","author":"Hegyi","year":"2008","journal-title":"Acta Dermatovenereol Alp Panonica Adriat"},{"key":"RU70-1-20210206","first-page":"785","article-title":"Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients.","volume":"101","author":"Fernandez-Guarino","year":"2010","journal-title":"Actas Dermos"},{"key":"RU71-1-20210206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-1261","article-title":"Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides.","volume":"92","author":"Kim","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"RU72-1-20210206","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0190-9622(08)81742-2","article-title":"Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.","volume":"31","author":"Wolf","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"RU73-1-20210206","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-0420.1999.770213.x","article-title":"Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and periocular skin.","volume":"77","author":"Wang","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"RU74-1-20210206","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/000155501750376276","article-title":"Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response.","volume":"81","author":"Edstrom","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"RU75-1-20210206","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1046\/j.1365-2133.2001.04245.x","article-title":"Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides.","volume":"144","author":"Markham","year":"2001","journal-title":"Br J Dermatol"},{"key":"RU76-1-20210206","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2230.2002.01119.x","article-title":"Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-Cell lymphoma.","volume":"27","author":"Leman","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"RU77-1-20210206","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-4632.2008.03177.x","article-title":"Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.","volume":"47","author":"Recio","year":"2008","journal-title":"Int J Dermatol"},{"key":"RU78-1-20210206","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1524-4725.2000.00056.x","article-title":"Photodynamic therapy of cutaneous lymphoma using 5-Aminolevulinic acid topical application.","volume":"26","author":"Orenstein","year":"2000","journal-title":"Dermatol Surg"},{"key":"RU79-1-20210206","first-page":"477","article-title":"Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.","volume":"7","author":"Paech","year":"2002","journal-title":"Eur J Med Res"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1111\/dsu.12319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T16:54:31Z","timestamp":1716051271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201312000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1111\/dsu.12319","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}